Last reviewed · How we verify

NCT07150494

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

Not yet recruiting Last updated 30 September 2025
What this trial tests

trial testing Phototherapy in Neonatal Hyperbilirubinemia in 80 participants. Not yet recruiting.

Timeline
1 October 2025
Primary endpoint
1 October 2026
1 October 2026

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment80
Start date1 October 2025
Primary completion1 October 2026
Estimated completion1 October 2026

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 1 Day to 28 Days, any sex, with Neonatal Hyperbilirubinemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early detection and prevention of neonatal encephalopathy using BIND score.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Phototherapy

Trials testing the same drug.

Other recruiting trials for Neonatal Hyperbilirubinemia

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07150494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing